Cardio Diagnostics to unveil coronary artery disease data, FDA designation strategy and India launch update on December 10
CDIO•Cardio Diagnostics said it will present non-obstructive coronary artery disease data, its FDA Breakthrough Device Designation strategy and an India launch update on a December 10 investor call.
1. Investor call planned
Cardio Diagnostics said it will present non-obstructive coronary artery disease data, its FDA Breakthrough Device Designation strategy and an India launch update on a December 10 investor call.




